Search results for “Tcr repertoire” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 54 patents, we discovered top 12 key players by total patent application. Immunocore Ltd., Adaptimmune Ltd., Neogene Therapeutics BV are dominant in this area. They take 79.63% of the total patent filing.
Immunocore Ltd.
United Kingdom
Patent: 16
Adaptimmune Ltd.
YORK COUNTY, United Kingdom
Patent: 14
Neogene Therapeutics BV
Netherlands
Patent: 13
Adaptive Biotechnologies Corp.
Washington, United States
Patent: 8
Institut National de la Santé et de la Recherche Médicale
France
Patent: 5
Centre National De La Recherche Scientif
France
Patent: 5
E. R. Squibb & Sons LLC
New Jersey, United States
Patent: 5
NantOmics LLC
California, United States
Patent: 2
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 2
IDAC Theranostics, Inc.
Tokyo-to, Japan
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 3 patents, we discovered top 2 start-ups by total patent application.
NantOmics LLC
California, United States
Patent: 2
STARTUP
Repertoire Genesis, Inc.
Osaka-fu, Japan
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 50 patents applied in the last 5 years. We discover 20 most active companies in this area. The fast-growing Neogene Therapeutics BV, Mie University, University of Kansas Medical Center take 50.00% of patent filing during this period.
Neogene Therapeutics BV
Netherlands
Patent: 13
Mie University
Mie-ken, Japan
Patent: 6
University of Kansas Medical Center
United States
Patent: 6
The Board of Regents of The University of Texas System
Texas, United States
Patent: 6
University of Oslo
Oslo, Norway
Patent: 3
University of Antwerp
Antwerpen, Belgium
Patent: 3
Oslo universitetssykehus HF
Oslo, Norway
Patent: 3
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 2
Adaptive Biotechnologies Corp.
Washington, United States
Patent: 2
NantOmics LLC
California, United States
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 50 patents in last 5 years, we discover 15 new entrants. Neogene Therapeutics BV, Mie University, University of Kansas Medical Center are the most active new entrants in this area.
Neogene Therapeutics BV
Netherlands
Patent: 13
Mie University
Mie-ken, Japan
Patent: 6
University of Kansas Medical Center
United States
Patent: 6
The Board of Regents of The University of Texas System
Texas, United States
Patent: 6
University of Oslo
Oslo, Norway
Patent: 3
University of Antwerp
Antwerpen, Belgium
Patent: 3
Oslo universitetssykehus HF
Oslo, Norway
Patent: 3
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 2
NantOmics LLC
California, United States
Patent: 2
Université d'Aix-Marseille
France
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 48 patents, we discovered top 11 universities and scientific research institutions by total patent application. University of Kansas Medical Center, Mie University, Universite Louis Pasteur Strasbourg I are dominant in this area. They take 43.75% of the total patent filing.
University of Kansas Medical Center
United States
Patent: 6
Mie University
Mie-ken, Japan
Patent: 6
Universite Louis Pasteur Strasbourg I
France
Patent: 4
University of Oslo
Oslo, Norway
Patent: 3
University of Antwerp
Antwerpen, Belgium
Patent: 3
University of Toyama
Okinawa-ken, Japan
Patent: 3
University of Tokyo
Tokyo-to, Japan
Patent: 2
Tokyo University of Science
Tokyo-to, Japan
Patent: 2
Université d'Aix-Marseille
France
Patent: 2
University of Strasbourg
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: